No is ignored

Timely Access to Neglected drugs and Point of Care Diagnostics

Diseases in focus

With advanced research, we create innovative drugs & diagonstics for a
healthier tomorrow.

Jolly Healthcare creates innovative vaccines and bio-therapeutics trusted by physicians around the world. We own 50 global patents and our products help people in over 65 countries live to their fullest potential. Our manufacturing facilities are approved by USFDA, KFDA and WHO.

Cryptococcal Meningitis

Cryptococcal meningitis is a serious infection of the brain and spinal column that can occur in people living with HIV.

Wilson Disease

Wilson disease is a rare genetic disorder characterized by excess copper stored in various body tissues, particularly the liver, brain, and corneas of the eyes.

Congenital Hyperinsulinism

Congenital hyperinsulinism (HI) is the most frequent cause of severe, persistent hypoglycemia caused by excessive insulin secretion in newborn babies and children.

Complex Partial Seizures(Epilepsy)

A Refractory complex partial seizure (CPS) is a type of seizure that starts in a specific area of the brain and can affect consciousness.

Rare There
are Diseases


There are approx

7k rare disease

FDA lists

456 drugs in the
short supply

Reasons of shortage of drugs

  • Active ingredients shortage.
  • Price capping by ....
  • Regulatory issues
  • Manufacturing problems
  • Supply chain management.

Advantage of ..... Testing

  • Low cost
  • Portability
  • Simplicity
  • Remote Accessibility
  • Built-in quality control

Our Ever Growing Coverage

0 +
Scientific Officer
0 +
Hospitals Served
0 +
Distribution Points
0 +
Countries Exported

Doctors is at the core of our planning, our thinking and our actions

The future of healthcare

At Jolly healthcare we believe in patient-first approach
research and manufacturing to offer high- quality and
affordable medicine.


From the Concept to the Drug

JOLLY covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.


Partnering is of key importance for Jolly healthcare. It allows further developing Jolly Healthcare’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.



In the field of rare diseases the Jolly healthcare team develops and investigates therapy options for patients with rare Neglected diseases – commitment and appreciation are the essence of our cooperative work.

Ethical Sourcing

Finding precise diagnosis and medicines for rare diseases.


Partnering & Collaboration

Join Us

Jolly Career for You

Quality is not an act, it is a habit

Clear FOCUS on DOCTORS, Growth with Partners Access to HARD TO FIND Drugs & Diagnostics ENABLING DOCTORS Worldwide ”

Mr. Avish Jolly

Best Science for the Neglected

Jolly healthcare is a doctor driven organization for making timely access to Neglected drugs

Aijaz Ansari
Director, Jolly Healthcare